Phentolamine: Indications, Dosing, and Contraindications
Phentolamine is a nonselective α-adrenergic blocker indicated primarily for pheochromocytoma-related hypertensive crises, prevention/treatment of norepinephrine extravasation, and sympathomimetic toxicity—not for routine hypertensive emergencies. 1
Primary Indications
1. Pheochromocytoma Management
- Preoperative blood pressure control: Administer 5 mg IV or IM (1 mg in children) 1–2 hours before surgery, repeated as necessary to prevent hypertensive paroxysms. 1
- Intraoperative hypertensive crises: Give 5 mg IV (1 mg in children) during surgery to control acute blood pressure spikes, tachycardia, or catecholamine-induced complications. 1
- Diagnostic testing (phentolamine blocking test): Inject 5 mg IV (1 mg in children) after stabilizing baseline blood pressure; a positive response (systolic drop >35 mmHg, diastolic >25 mmHg within 2 minutes) suggests pheochromocytoma but requires confirmation with urinary catecholamine measurements. 1
2. Norepinephrine Extravasation
- Prevention: Add 10 mg phentolamine to each liter of norepinephrine infusion without affecting pressor activity. 1
- Treatment: Inject 5–10 mg phentolamine in 10 mL saline into the extravasation site within 12 hours to prevent dermal necrosis and tissue sloughing. 1
3. Sympathomimetic Toxicity (Amphetamine/Cocaine/MDMA)
- After benzodiazepine failure: The European Society of Cardiology recommends phentolamine for refractory hypertension in amphetamine/MDMA intoxication only after adequate sedation with benzodiazepines, which remain first-line therapy. 2, 3
- Dosing in toxicity: Use 5–10 mg IV titrated to effect, targeting a 20–25% reduction in mean arterial pressure within the first hour, then gradual reduction to <160/100 mmHg over 2–6 hours. 2
- Critical contraindication: Never use β-blockers (including labetalol) in sympathomimetic toxicity, as unopposed α-stimulation causes paradoxical hypertension; phentolamine provides selective α-blockade. 2, 3
Absolute Contraindications
- Myocardial infarction (current or history). 1
- Coronary insufficiency or angina. 1
- Any evidence of coronary artery disease. 1
- Hypersensitivity to phentolamine or related compounds. 1
Dosing Regimens by Indication
| Indication | Adult Dose | Pediatric Dose | Route | Timing |
|---|---|---|---|---|
| Pheochromocytoma (preop) | 5 mg | 1 mg | IV or IM | 1–2 h before surgery [1] |
| Pheochromocytoma (intraop) | 5 mg | 1 mg | IV | As needed during surgery [1] |
| Norepinephrine extravasation | 5–10 mg in 10 mL saline | Same | Local infiltration | Within 12 h of extravasation [1] |
| Sympathomimetic toxicity | 5–10 mg titrated | Not specified | IV | After benzodiazepines [2] |
| Diagnostic test | 5 mg | 1 mg | IV (rapid) | After 30 min BP stabilization [1] |
Critical Clinical Considerations
When Phentolamine Is NOT Appropriate
- Routine hypertensive emergencies: Nicardipine, labetalol, or clevidipine are preferred first-line agents for most hypertensive emergencies; phentolamine is reserved for catecholamine-excess states. 4
- Hypertensive urgency (no organ damage): Oral agents (captopril, extended-release nifedipine, labetalol) are indicated—never IV phentolamine. 4
- Acute coronary syndrome: Nitroglycerin is first-line; phentolamine is contraindicated due to coronary disease exclusion. 4, 1
Sympathomimetic Toxicity Algorithm
- First-line: Benzodiazepines (diazepam) to reduce catecholamine surge and control hypertension/tachycardia. 2, 3
- Second-line (if BP remains >180/120 mmHg): Phentolamine or nicardipine IV. 2
- Avoid: β-blockers as monotherapy (risk of unopposed α-stimulation). 2, 3
- Adjunct for coronary ischemia: Add nitroglycerin and aspirin. 2
Monitoring Requirements
- Diagnostic test: Record blood pressure every 30 seconds for 3 minutes, then every 60 seconds for 7 minutes after injection; maximal effect occurs within 2 minutes. 1
- Therapeutic use: Continuous cardiovascular monitoring in ICU settings for pheochromocytoma or sympathomimetic toxicity. 2
- Hypotension management: If dangerous blood pressure drops occur, treat with norepinephrine (postoperatively after pheochromocytoma removal). 1
Common Pitfalls
- Misusing phentolamine for routine hypertensive emergencies: This drug is not a first-line agent for most hypertensive crises; nicardipine or labetalol are preferred unless catecholamine excess is confirmed. 4, 2
- Administering before benzodiazepines in sympathomimetic toxicity: Benzodiazepines must be optimized first to address the underlying catecholamine surge. 2, 3
- Ignoring coronary contraindications: Phentolamine is absolutely contraindicated in any patient with coronary artery disease, angina, or MI history. 1
- Delaying extravasation treatment: Phentolamine must be infiltrated within 12 hours of norepinephrine extravasation to prevent tissue necrosis. 1
- Over-reliance on diagnostic testing: A negative phentolamine test does not exclude pheochromocytoma, especially in paroxysmal hypertension; urinary catecholamine measurements are required for confirmation. 1
Alternative Uses (Non-Hypertensive)
- Reversal of local anesthesia: Phentolamine 0.4 mg (OraVerse) reduces median lip recovery time by 75–85 minutes after dental procedures, with mild conjunctival hyperemia as the primary adverse effect. 5, 6
- Reversal of pharmacologic mydriasis: 0.75% phentolamine ophthalmic solution reverses pupil dilation within 60–90 minutes, reducing time to baseline by 5–6 hours compared to placebo. 7
- Erectile dysfunction: Oral phentolamine 40–80 mg has shown modest efficacy in mild-to-moderate ED, though not FDA-approved for this indication. 8, 9